Zepbound vs Contrave: Tirzepatide Injection vs Oral Naltrexone-Bupropion
Zepbound (tirzepatide, Eli Lilly) vs Contrave (naltrexone-bupropion, Currax Pharmaceuticals)
Last verified 2026-05-28
The verdict
For raw efficacy, Zepbound wins decisively: SURMOUNT-1 showed -20.9% body weight at 72 weeks on the 15 mg dose versus -6.1% for Contrave in COR-I at 56 weeks. Zepbound also has an FDA-approved OSA indication (SURMOUNT-OSA, 2024) that Contrave lacks. Contrave's edge is practical: it is fully oral, ~$99/month cash, and avoids GLP-1-class GI burden. Zepbound makes sense when the goal is maximum loss; Contrave fits patients who cannot inject, cannot afford GLP-1 pricing, or have appetite-driven eating.
Side-by-side comparison
| Field | Zepbound | Contrave |
|---|---|---|
| Drug class | Dual GIP/GLP-1 receptor agonist | Opioid antagonist + aminoketone antidepressant |
| Route & frequency | Subcutaneous injection, once weekly | Oral tablet, twice daily |
| Pivotal trial weight loss | -20.9% at 72 weeks (SURMOUNT-1, 15 mg) | -6.1% at 56 weeks (COR-I, full dose) |
| FDA approval (chronic weight management) | November 2023 | September 2014 |
| Additional FDA-approved indications | Moderate-to-severe OSA in adults with obesity (Dec 2024, per SURMOUNT-OSA) | None beyond chronic weight management |
| Typical US cash price | $349-$499/month via LillyDirect vials (dose-dependent) | ~$99/month via Currax cash-pay program |
| Most common adverse events | Nausea (~29%), diarrhea, constipation, vomiting | Nausea, constipation, headache, insomnia, dry mouth |
| Boxed warning | Thyroid C-cell tumors (rodent finding) | Suicidal thoughts and behaviors in young adults (bupropion class) |
| Notable contraindications | Personal/family history of medullary thyroid carcinoma or MEN 2 | Uncontrolled hypertension, seizure disorders, chronic opioid use, MAOI use |
Frequently asked questions
How much more weight loss does Zepbound deliver compared to Contrave?
In their respective pivotal trials, Zepbound 15 mg produced -20.9% body weight at 72 weeks (SURMOUNT-1), while Contrave at full dose produced -6.1% at 56 weeks (COR-I). That is roughly 3-4x more weight loss with Zepbound, though the trials differ in duration and population, so the comparison is directional rather than head-to-head.
Is Contrave a cheaper alternative to Zepbound?
Yes. Contrave's Currax cash-pay program runs around $99/month, while Zepbound through LillyDirect ranges roughly $349-$499/month depending on dose. The trade-off is efficacy: patients paying less for Contrave will, on average, lose substantially less weight.
Can Contrave treat sleep apnea like Zepbound?
No. Zepbound is the first medication FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity, based on SURMOUNT-OSA (Malhotra 2024 NEJM). Contrave has no OSA indication and was not studied for that endpoint.
Who is Contrave the better fit for despite lower efficacy?
Patients who cannot or will not inject, cannot afford GLP-1 pricing, do not tolerate GLP-1 GI side effects, or have prominent food cravings and reward-driven eating, since Contrave's bupropion-naltrexone mechanism targets central reward pathways. It is also a reasonable option when insurance covers it but excludes GLP-1s.
What boxed warnings should I know about for each drug?
Zepbound carries a boxed warning for thyroid C-cell tumors based on rodent studies; it is contraindicated in patients with personal or family history of medullary thyroid carcinoma or MEN 2. Contrave carries a boxed warning for suicidal thoughts and behaviors in children, adolescents, and young adults, inherited from the bupropion component.
Can Zepbound and Contrave be combined?
Combination therapy is not FDA-approved or studied in pivotal trials and is generally not recommended outside of specialist obesity-medicine care. Bupropion has CNS-stimulating effects and Zepbound suppresses appetite via gut hormones, so stacking them without supervision risks overlapping side effects without clear added benefit.
References
Related comparisons
- Wegovy vs Zepbound
- Ozempic vs Mounjaro
- Semaglutide vs Tirzepatide
- Rybelsus vs Ozempic
- Mounjaro vs Zepbound
- Foundayo vs Rybelsus
See the full drug-vs-drug verdict index or provider rankings.